The findings by physicists from the University of Sydney show how a nanoscale, synthetic version of the precious gem can light up early-stage cancers in non-toxic, non-invasive Magnetic Resonance Imaging (MRI) scans.
Targeting cancers with tailored chemicals is not new but scientists struggle to detect where these chemicals go since, short of a biopsy, there are few ways to see if a treatment has been taken-up by a cancer.
Led by Professor David Reilly from the School of Physics, researchers investigated how nanoscale diamonds could help identify cancers in their earliest stages.
"We thought we could build on these non-toxic properties realising that diamonds have magnetic characteristics enabling them to act as beacons in MRIs. We effectively turned a pharmaceutical problem into a physics problem," he said.
More From This Section
Reilly's team turned its attention to hyperpolarising nano-diamonds, a process of aligning atoms inside a diamond so they create a signal detectable by an MRI scanner.
"By attaching hyperpolarised diamonds to molecules targeting cancers the technique can allow tracking of the molecules' movement in the body," said Ewa Rej, lead author of the research paper published in the journal Nature Communications.
The next stage of the team's work involves working with medical researchers to test the new technology on animals.